InsidersTradesSigma
Follow the 광동제약 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Food & Beverage sector, 광동제약 has recorded 6 public disclosures. Market capitalisation: €300bn. The latest transaction was disclosed on 30 June 2026 (Other). Among the most active insiders: 최성원. The full history is accessible without an account.
6
Insider Decl.
n/a
Thresholds
€81,964
3 ops.
Buy Volume
n/a
1 ops.
Sell Volume
31Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 15,118 of 29,062 companies
50.9
score / 100
Value74
Quality28
FCF yld18%
Earn yld6.6%
EV/EBITDA10.3x
ROE3.5%
Gross mgn18%
Net mgn1.3%
Debt/EBITDA5.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 30 June 2026
Declarations6 total
6 of 6 declarations
Acerca de 광동제약
광동제약 es una empresa surcoreana especializada en la fabricación de productos farmacéuticos y de salud. Cotiza en la bolsa de valores XKRX.